Covidien Management Discusses Q2 2013 Results – Earnings Call Transcript

Published April 29, 2013

Covidien Management Discusses Q2 2013 Results – Earnings Call Transcript

Filed under: New Mexico Drug Treatment Centers

We continue to see stroke as an attractive market, and see opportunity for the new generation of treatment devices such as Solitaire for mechanical thrombectomy. We plan to augment our investments in technology and clinical trials to further establish …
Read more on Seeking Alpha

Curis Announces Erivedge(R) Receives Positive CHMP Opinion for Conditional …

Filed under: New Mexico Drug Treatment Centers

LEXINGTON, Mass., April 26, 2013 (GLOBE NEWSWIRE) — Curis, Inc. (CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, today announced that the Committee for Medicinal Products for Human …
Read more on Yahoo! New Zealand News